Range
- - -
Vol / Avg.
1.1K/8.1M
Div / Yield
-
52 Wk
1.03 - 7.45
Mkt Cap
339.8M
Payout Ratio
-
Open
-
P/E
156
EPS
-0.04
Shares
217.9M
Outstanding
217.9M
Total Float
217.3M
Benzinga - May 7, 2021, 10:42AM
Benzinga - May 5, 2021, 2:04PM
load more
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-08
REV
Q3 2021Est.ActualSurprise
EPS-0.040
REV800.000K765.000K-35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IBIOiBio3.21%339.8M

iBio Frequently Asked Questions

Q

How do I buy iBio (IBIO) stock?

A

You can purchase shares of iBio (AMEX: IBIO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are iBio's (IBIO) competitors?

A

There are no as such competitors for iBio.

Q

What is the target price for iBio (IBIO) stock?

A

The latest price target for iBio (AMEX: IBIO) was reported by Cantor Fitzgerald on January 22, 2021. The analyst firm set a price target for 3.00 expecting IBIO to rise to within 12 months (a possible 92.31% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for iBio (IBIO)?

A

The stock price for iBio (AMEX: IBIO) is $1.56 last updated Wed Jun 23 2021 19:59:58 GMT+0000 (Coordinated Universal Time).

Q

Does iBio (IBIO) pay a dividend?

A

There are no upcoming dividends for iBio.

Q

When is iBio (AMEX:IBIO) reporting earnings?

A
iBio’s Q4 earnings are confirmed for after-market on August 8, 2021.
Q

Is iBio (IBIO) going to split?

A

There is no upcoming split for iBio.

Q

What sector and industry does iBio (IBIO) operate in?

A

iBio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the AMEX.